Capital Change Notice

Capital Change Notice




Section 1: Issuer information
Name of issuer Ryman Healthcare Limited
NZX ticker code RYM010
Class of financial product Fixed rate, secured, unsubordinated
bonds (“Bonds”)
ISIN (If unknown, check on NZX website) NZRYMD0010L2
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 150,000,000
Nominal value (if any) $1.00
Issue/acquisition/redemption price per security $1.00
Nature of the payment (for example, cash or other
consideration)
Cash
Amount paid up (if not in full) Fully paid up
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury
Stock, in existence)
100%
For an issue of Convertible Financial Products or
Options, the principal terms of Conversion (for example
the Conversion price and Conversion date and the
ranking of the Financial Product in relation to other
Classes of Financial Product) or the Option (for
example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and specific
authority for issue/acquisition/redemption/ (the reason
for change must be identified here)
The purpose of the offer is to provide
diversity of funding sources and
tenor, and the proceeds of the offer
will be used to repay a portion of
Ryman’s existing bank debt. This will
provide Ryman with additional
headroom under Ryman’s Bank
Facility Agreement which it can
drawdown as required.

Issue authorised by resolution of the
Board at a meeting on 23 November
2020.
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding
Treasury Stock) and the total number of Financial
Products of the Class held as Treasury Stock after the
issue/acquisition/redemption.
150,000,000

In the case of an acquisition of shares, whether those
shares are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or
redemption, including a reference to the rule pursuant to
which the issue, acquisition, or redemption is made
Issue authorised by resolution of the
Board at a meeting on 23 November
2020.
Rule 3.13.1
Terms or details of the issue, acquisition, or redemption
(for example: restrictions, escrow arrangements)
As described in the Product
Disclosure Statement dated 26
November 2020.
Date of issue/acquisition/redemption 18 December 2020
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement
David Bennett, Chief Financial
Officer
Contact person for this announcement David Bennett
Contact phone number 0800 588 222
Contact email address david.bennett@rymanhealthcare.com
Date of release through MAP

18 December 2020